+ Follow PHARMACEUTICALS DIVISION Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 654976
[Title] => Roche posts solid results in 2010
[Summary] => The Roche Group posted solid overall results in 2010. Group sales were stable in local currencies at 47.5 billion Swiss francs.
[DatePublished] => 2011-02-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[1] => Array
(
[ArticleID] => 595712
[Title] => Roche posts strong first half results
[Summary] => Roche CEO Severin Schwan announced yesterday that “Roche achieved a strong operating performance in the first half of 2010 despite an increasingly challenging market environment.
[DatePublished] => 2010-07-24 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[2] => Array
(
[ArticleID] => 551569
[Title] => Greater chances of cure for patients with breast cancer
[Summary] => Roche announced recently its new long-term follow up-data from two large pivotal studies evaluating adjuvant trastuzumab in HER2-positive early- stage breast cancer presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
[DatePublished] => 2010-02-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
)
)
PHARMACEUTICALS DIVISION
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 654976
[Title] => Roche posts solid results in 2010
[Summary] => The Roche Group posted solid overall results in 2010. Group sales were stable in local currencies at 47.5 billion Swiss francs.
[DatePublished] => 2011-02-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[1] => Array
(
[ArticleID] => 595712
[Title] => Roche posts strong first half results
[Summary] => Roche CEO Severin Schwan announced yesterday that “Roche achieved a strong operating performance in the first half of 2010 despite an increasingly challenging market environment.
[DatePublished] => 2010-07-24 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[2] => Array
(
[ArticleID] => 551569
[Title] => Greater chances of cure for patients with breast cancer
[Summary] => Roche announced recently its new long-term follow up-data from two large pivotal studies evaluating adjuvant trastuzumab in HER2-positive early- stage breast cancer presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
[DatePublished] => 2010-02-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
)
)
abtest
February 8, 2011 - 12:00am
February 22, 2010 - 12:00am